Exel Inc. d/b/a DHL Supply ChainMarch 13, 2020

FDA 483 - Exel Inc. d/b/a DHL Supply Chain - March 13, 2020

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Exel Inc. d/b/a DHL Supply Chain

Record Details

Exel Inc. d/b/a DHL Supply Chain in Manchester, PA, a drug repacker/relabeler, received a Form 483 with two observations. The inspection revealed that the firm failed to thoroughly investigate unexplained discrepancies related to incorrect drug quantities in distributed products. Additionally, the firm did not conduct GMP training with sufficient frequency for employees involved in repacking and relabeling operations.

Company: Exel Inc. d/b/a DHL Supply Chain
Inspection Date: March 13, 2020
Product Type: Drugs
Office: Philadelphia District Office
Person: David A. Oluwo (Pharmacy Intern/Certified Pharmacy Technician)

Open in Dashboard

ID · 6d4687c7-89f5-4e32-850a-f837f18832d4